Assessment of treatment patterns of severe asthmatic patients across the Gulf region – SevEos study

Trial Identifier:	D2287R00124
Sponsor:	AstraZeneca
NCTID::	NCT03387722
Start Date:	December 2017
Primary Completion Date:	January 2019
Study Completion Date:	January 2019

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Oman	Muscat, Oman, 111
United Arab Emirates	United Arab Emirates

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.